Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.45
-0.27 (-2.47%)
May 13, 2025, 12:48 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Oral Health | 3.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Health Growth | 5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins, Minerals and Supplement | 1.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins, Minerals and Supplement Growth | 1.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pain Relief | 2.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pain Relief Growth | -1.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Health | 1.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Health Growth | -1.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive Health and Other | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive Health and Other Growth | -9.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| North America | 4.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | -2.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm | 4.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm Growth | -0.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC | 2.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Growth | 1.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2018 - 2019 |
| North America Adjusted Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Adjusted Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm Adjusted Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA & LatAm Adjusted Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Adjusted Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Adjusted Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales Growth due to Price |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales Growth due to Volume/Mix |
Log In |
Log In |
Log In |
Log In | Upgrade
|